6640--RNA Scope

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 intends to award a sole source contract to BIO-TECHNE SALES CORPORATION for RNA Scope multiplex RNA in situ hybridization (ISH) assays, probes, reagents, and controls for the VA Medical Center in Providence, Rhode Island. The procurement supports neuropathology research focusing on protein synthesis, neurotransmitter release, and cellular biosynthesis processes, with specific requirements for probes targeting genes including EIF4H, STXBP5, UCK2, and PSEN2, along with negative and positive control probes. The contract will utilize a Leica Bond RX system for processing human frozen tissue samples, and BIO-TECHNE is identified as the exclusive manufacturer and sole source vendor for these advanced scientific RNA Scope-ISH products. The procurement is authorized under FAR 6.302.1-1 as only one responsible source exists that can satisfy the agency's requirements. Interested parties must submit responses by September 26, 2025, no later than 10:00 AM EST, with inquiries directed to the Contracting Specialist at andrew.simard@va.gov.

This procurement does not utilize any set-aside designations and is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees and Product Service Code 6640 for laboratory equipment and supplies. BIO-TECHNE SALES CORPORATION, located at 614 McKinley Place NE, Minneapolis, MN 55413-2610, is the intended sole source contractor for this award. The contract requires delivery of 2-3 units of each specified RNA Scope product to support the research objectives at the Providence facility. Since this is a pre-solicitation notice for a sole source award, no formal solicitation will be posted to SAM.gov, and the determination to conduct any competitive procurement based on responses to this notice remains solely at the discretion of the Contracting Officer. The contract award is intended specifically for the Providence VA Medical Center location to support their ongoing neuropathology research initiatives.